Related Experiment Video
Updated: Oct 27, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Evaluation of phlebitis adverse event occurrence in patients of a Clinical Inpatient Unit
Maryana da Silva Furlan1, Antônio Fernandes Costa Lima2
1Universidade de São Paulo, Escola de Enfermagem, Programa de Pós-Graduação em Enfermagem, São Paulo, SP, Brasil.
Objective:
To analyze the causes and reasons associated with the occurrence of phlebitis in a Inpatient Medical Unit in a large and private general hospital.
Method:
Quantitative, exploratory-descriptive, retrospective and documentary research, carried out by consulting the electronic forms of notification of the occurrence of phlebitis in 2017.
Results:
A total of 107 phlebitis related to 96 patients were reported, most of them (91.7%) with phlebitis, being male (53.1%), aged 60-69 years old (23.0%) and with a hospital stay of less than four days (30.2%). Most (68.2%) of the notifications were made by nurses, with the occurrence of phlebitis predominating in devices with less than 24h (38.3%); with the classification of phlebitis grade 2 (45.8%); with antibiotics infusion (46.7%); with the location of the bed far from the nursing station (52.3%); and with the presence of a companion (82.2%). The damage classification indicated that 93.5% of the patients suffered mild damage, 4.7% moderate damage and 1.9% did not suffer any damage.
Conclusion:
Knowing the causes and reasons associated with the occurrence of phlebitis can support decision-making, management and care processes regarding investments in preventive or risk mitigation strategies.
Related Concept Videos
Endocarditis IV: Nursing Management
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

